Event: Microbiome Connect: Gut Therapeutics

November 17th – 18th

Clinical data continues to implicate the gut microbiome in an array of indications, evidencing the vast potential as a future drug target and source of biomarkers.

We are approaching a pivotal time in the industry’s development. The global human microbiome therapeutics market is forecasted to be worth $ 1,544 million by 2027! With 27% of microbiome drugs are entering phase 2 trials. It is time to cement your foundations to ready yourself for the incoming market boom.

Microbiome Connect: Gut Therapeutics will bring you essential solutions to the array of challenges operating in the microbiome field. The event will facilitate your discussions, uniting academics, biotechs and other industry stakeholders to share their exclusive research and innovation. Hear from big pharma to understand what they look for in a partner.

Contact Us

Talk with an expert

Request a quote for our services or more information on sample types and handling procedures, need a letter of support, or simply have questions about how metabolomics can advance your research.

Corporate Headquarters

617 Davis Drive, Suite 100
Morrisville, NC 27560

Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709

+1 (919) 572-1711

+1 (919) 572-1721

International Headquarters

Metabolon GmbH

Zeppelinstraße 3
85399 Hallbergmoos

+49 89 99017752
This site is registered on wpml.org as a development site.